
Boston Scientific wins FDA nod for Farapoint PFA catheter
A Boston Scientific (NYSE: BSX)+
executive said on social media that the company received FDA approval for its Farapoint pulsed field ablation (PFA) catheter.

A Boston Scientific (NYSE: BSX)+
executive said on social media that the company received FDA approval for its Farapoint pulsed field ablation (PFA) catheter.

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG system.

Minneapolis-based Imricor Medical Systems (ASX:IMR) said it won 510(k) clearance from the FDA for its Vision-MR Diagnostic Catheter.

SINGAPORE, Jan. 6, 2026 /PRNewswire/ — Spectrumedics Medical (hereinafter “Spectrumedics”) is pleased to announce that its Sonico-CX Intravascular Lithotripsy (IVL) System has obtained CE Mark certification under the European Union Medical Device Regulation (EU MDR). The system comprises the Sonico-CX Coronary Intravascular Lithotripsy Catheter and the Intravascular Lithotripsy Generator.

Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published by researchers in the Institute for Biomedical Sciences at Georgia State University.

Scientists at the Paul Scherrer Institute PSI have refined an X-ray diffraction technique for detecting biological structures from nanometers to millimeters—reducing the time needed to make the measurement from around one day to about an hour. This opens up a wide range of possibilities for biomedical research—from analyzing bone and tissue structures to supporting the development of new implants.

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition to develop pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer), as well as the prognosis of the disease once it has appeared.

Sinai Health researchers have shown a blood test that can predict Crohn’s disease years before symptoms appear, opening the doors to early diagnosis and potentially prevention.

Parkinson’s disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra, a brain region essential for motor control. Clinically, it is marked by tremor, rigidity, bradykinesia and postural instability, symptoms that progressively erode independence and quality of life.

Georgetown University’s Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing cancer cells.